Related Experiment Videos
Deep learning for cardiovascular disease: a comprehensive review of detection and risk forecasting
1School of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, India.
Insights
Deep learning models integrating multimodal data significantly improve cardiovascular disease (CVD) early detection and risk assessment. These advanced AI approaches achieve high accuracy, offering personalized recommendations for better clinical practice and prevention.
Area of Science:
- Artificial Intelligence in Medicine
- Cardiovascular Disease Research
- Deep Learning Algorithms
Background:
- Cardiovascular disease (CVD) is a leading global health threat, necessitating improved risk analysis for clinical practice and prevention.
- Emerging data modalities like wearable sensors, EHRs, and genomics enable holistic CVD risk assessment via multimodal data integration.
Purpose of the Study:
- To systematically review and analyze deep learning algorithms using multimodal data for early CVD detection and risk stratification.
- To characterize diverse data streams and deep learning fusion methods applied in CVD risk assessment.
Main Methods:
- Systematic review following PRISMA 2020 guidelines, analyzing 69 studies.
- Characterization of data streams including physiological, imaging, EHR, and genomic data.
- Analysis of deep neural networks (CNNs, RNNs, BiGRU, CNN-LSTM) with various fusion techniques (early, late, attention-based).
Main Results:
- Deep learning models demonstrate dramatic improvements in predictive accuracy (often >98%) for CVD risk.
- Models show enhanced robustness to missing or noisy data and enable real-time, individualized recommendations.
- Top models like DEEP-CARDIO BiGRU-Attention achieved 99.9% accuracy; federated FL-LSTM reached 99% AUC with privacy protection.
Conclusions:
- Multimodal deep learning offers a powerful paradigm shift for early CVD detection and personalized risk assessment.
- Explainable AI methods (Grad-CAM, SHAP) are crucial for understanding model predictions in imaging and structured data.
- Future directions include systematic reproducibility, federated learning, equitable AI, and regulatory translation for clinical implementation.
Abstract:
The biggest health threat to the global population is cardiovascular disease (CVD), which afflicts almost one-third of the global population and causes considerable monetary and social losses. Risk analysis should be performed in a timely and appropriate manner to enhance clinical practice and preventive interventions. The emergence of advanced data modalities, such as wearable sensors, medical imaging, electronic health records (EHRs), and genomic platforms, has led to a paradigm shift in the holistic assessment of CVD risk through multimodal data integration. This systematic review is a methodological analysis of recent multimodal input deep-learning algorithms that enhance the early detection of CVD and risk-specific evaluation, following PRISMA 2020 guidelines across 69 studies published 20,122,025 based on 2,847 initial database records. We characterized the wide range of available data streams: longitudinal physiological measurements (ECG, HRV, and BP), echocardiogram data, cardiac MRI and CT, lab/demographic data, behavioral/environmental data, and genomic/proteomic data. Mid-level, early, late, and attention-based fusion methods are described in the context of deep neural networks, such as CNNs, RNNs, BiGRU with attention, and hybrid CNN-LSTM networks. Comparative studies showed dramatic improvements in predictive accuracy (often over 98%), strength to missing or noisy modalities, and access to real-time, individualized recommendations. The best-performing DEEP-CARDIO BiGRU-Attention model had 99.9 percent accuracy on Framingham and Statlog benchmarks. A systematic review of 28 studies by Grad-CAM and SHAP confirmed the dominance of each in imaging and structured-data tasks, respectively (Rahman et al., 2024). The federated explainable FL-LSTM model achieved 99% AUC across three ECG databanks with complete privacy protection. We end with a systematic reproducibility, federated learning, equitable AI, and regulatory translation roadmap.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease I: Introduction